Odds ratios of severe COVID-19 according to prescription drug use among 4,114 infected participants.
figure
posted on 2024-11-27, 18:40 authored by Aleksander Eiken, Sofie Bliddal, Marie Villumsen, Kasper K. Iversen, Henning Bundgaard, Rasmus B. Hasselbach, Jonas H. Kristensen, Pernille B. Nielsen, Mia M. Pries-Heje, Andreas D. Knudsen, Kamille Fogh, Jakob B. Norsk, Ove Andersen, Thea K. Fischer, Ram B. Dessau, Sisse R. Ostrowski, Christian Torp-Pedersen, Sisse B. Ditlev, Mikkel Gybel-Brask, Erik Sørensen, Lene H. Harritshøj, Fredrik Folke, Thomas Benfield, Frederik N. Engsig, Henrik E. Poulsen, Henrik Ullum, Ulla Feldt-Rasmussen, Susanne D. Nielsen, Jørgen RungbyCrude odds ratios of a severe COVID-19 infection when comparing use versus no use (reference) of prescription drugs in the six months prior to a PCR SARS-CoV-2 positive test. Severe COVID-19 was defined as hospitalization for more than 48 hours with time of admission within 14 days of a positive SARS-CoV-2 PCR test.
History
Usage metrics
Categories
Keywords
danish health registerscalcium channel blockerscalcium channel blocker66 &# 821162 &# 821115 &# 821109 &# 8211uninfected controls basedspecific drug groupsspecific drug classesconditional logistic regressioncrude odds radiopatient characteristics camepast month increasedknown risk factorsamong infected participants49 &# 8211prescription drug useversus drug usagedeveloping severe covidadjusted odds ratioci ): 02 infection accordingvasoprotective drugsevere covidpatient contactpast sixone monthlogistic regressionshospitalizations camedrug class021 controlsprescription redemptionxlink ">six monthspositive pcronline surveysobservational studymodels assessinginvestigated druginfection comparedinfected individualsinfected casesfindings suggestdrug exposureconfidence intervalclarify interactionschronic diseases74 ci61 ).2 positivity2 infections2 infection08 ),
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC